Riskpilot← Back to searchSign inGet full accessVacse Instrumentet 1 AB
ABActiveOrg 5569713042Kungsgatan 24Rental and operating of own or leased real estate · NACE 6820Est. 20140 employees
Revenue 2025
SEK 16,7M
+1% vs 2024
EBITDA margin
91.8%
+39% vs 2024
Equity ratio
8.1%
Financial strength
Net profit 2025
SEK 5,3M
+253% vs 2024
| Revenue | SEK 16,7M | +1% |
| EBITDA | SEK 15,3M | +39% |
| Net profit | SEK 5,3M | +253% |
| Total assets | SEK 137,1M | +3% |
| Equity | SEK 11,1M | +26% |
| Employees | 0 | — |
Legal name
Vacse Instrumentet 1 AB
Org number
5569713042
Legal form
Aktiebolag
NACE code
6820 · Rental and operating of own or leased real estate
Founded
12 maj 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Föremål för bolagets verksamhet är förvärv, förvaltning och försäljning av fast egendom samt därmed förenlig verksamhet.
Address
Kungsgatan 24
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 14 288 | 14 142 | 14 630 | 14 339 | 14 687 | 15 847 | 16 482 | 16 661 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −5 | −109 | −434 | 246 | 388 | 542 | 214 | 4 313 | 10 828 | 10 976 | 15 301 |
| Depreciation & amort. | −0 | −0 | — | — | — | — | — | — | — | — | −1 523 |
| EBIT | −5 | −109 | −434 | 246 | 388 | 542 | 214 | 4 313 | 10 828 | 10 976 | 11 185 |
| Net financials | — | −877 | −1 713 | −2 800 | −3 130 | −2 935 | −2 702 | −2 536 | −4 653 | −4 431 | −4 344 |
| Profit before tax | 0 | 5 | −2 147 | 5 849 | 2 399 | 1 199 | 3 598 | 2 399 | 6 175 | 2 400 | 6 841 |
| Tax | −0 | −0 | 247 | −1 009 | −494 | −247 | −494 | −713 | −1 787 | −891 | −1 519 |
| Net profit | 0 | 5 | −1 900 | 4 840 | 1 905 | 952 | 3 104 | 1 686 | 4 388 | 1 509 | 5 321 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 50 | 121 365 | 183 150 | 182 753 | 181 324 | 162 445 | 165 398 | 142 052 | 152 638 | 132 445 | 137 054 |
| Equity | 50 | 55 | −545 | 4 295 | 6 200 | 2 652 | 4 756 | 1 943 | 7 252 | 8 760 | 11 081 |
| Long-term debt | 0 | 121 248 | 178 868 | 172 835 | 169 284 | 153 770 | 153 977 | 131 978 | 135 324 | 112 902 | 115 051 |
| Short-term debt | 0 | 62 | 4 540 | 4 860 | 4 583 | 4 519 | 4 667 | 5 421 | 6 891 | 7 118 | 6 763 |
| Total debt | — | 121 310 | 183 408 | 177 695 | 173 867 | 158 289 | 158 644 | 137 399 | 142 215 | 120 020 | 121 814 |
EBITDA margin
91.8%
This company
15.8%
Market median
+481% vs market
20152025
Equity ratio
8.1%
This company
38.2%
Market median
-79% vs market
20152025
Return on equity
48.0%
This company
18.4%
Market median
+161% vs market
20152025
Net profit margin
31.9%
This company
8.1%
Market median
+294% vs market
20152025
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
20152025
Debt / equity
11.37×
This company
0.62×
Market median
-1734% vs market
20152025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
IC Chief Auditor | Chief Auditor | 2025 | — | — |
BM Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Vacse Ettan AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Vacse AB (publ)
Vacse Instrumentet 1 AB Board members of Vacse Instrumentet 1 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ida Christine Sparrfeldt | Chief Auditor | 0 companies |
| Björn Mikael Östblom | Chief Auditor | 0 companies |
| Axel Fredrik Linderborg | Chairman | 0 companies |
| Per Henrik Molin | Board of Directors | 0 companies |
| Sara Ulrika Gertrud Ravell Jägermo | Board of Directors | 0 companies |